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Generalized vitiligo (GV) is a complicated disease in which patchy depigmentation results from the
autoimmune loss of melanocytes from affected regions. It may follow a pattern of polygenetic or
multifactorial inheritance. Previously, a number of genetic susceptibility factors have been identiﬁed
through linkage and candidate gene studies, such as HLA, PTPN22, NALP1, and XBP1. Recently, a series of
genome-wide association studies have been carried out in different populations to further explore the
susceptibility variants for GV. More than 30 robust susceptibility loci have been identiﬁed and conﬁrmed.
Most of these associated genes encode components of biological pathways reaching from the immune
cell to the melanocytes. In this review, we summarize the advances of vitiligo epidemiology and genetics,
and highlight recent ﬁndings from genome-wide association studies, emphasizing susceptibility loci and
comparing the susceptibility loci between Chinese people and Caucasians. These genetic studies may
help in providing an insight into the pathogenesis of this disease and initiating the feasibility of genetic
diagnosis and personalized treatment for patients with GV in the future.
Copyright © 2014, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Generalized vitiligo (GV) is an acquired, noncontagious disorder
characterized by progressive, patchy loss of skin pigmentation, and
often overlying hair and mucous membranes, resulting from loss of
melanocytes in the affected areas.1e3 GV's underlying pathobiology
has remained largely unknown, although its striking phenotype has
been recognized for thousands of years.4 Clinical and epidemio-
logical investigations have indicated that vitiligo might follow a
pattern of polygenetic or multifactorial inheritance with approxi-
mately 50% heritability.5,6 Over the past several decades, a large set
of genes and genomic regions involved in GV susceptibility has
been revealed through linkage analysis and candidate gene studies.
However, genome-wide association studies (GWASs) have made a
huge success in discovering new GV susceptibility loci/genes. Most
of those loci/genes are related to the immune system and targeted
the destruction of melanocytes. The largest GV GWASs were carriedy have no ﬁnancial or non-
atter or materials discussed
atology, Huashan Hospital,
muqi Zhong Road, Shanghai
g).
cal Association. Published by Elsevout by Spritz et al5 in Caucasians and Zhang et al6 in Chinese people.
Compared to Caucasian GV GWASs, Chinese GV GWASs discovered
less susceptibility loci/genes.Epidemiological studies
GV is the most common depigmenting disorder, occurring with a
frequency of approximately 0.19% among the Chinese. Family
clustering of GVs exhibits a non-Mendelian pattern, with overall
vitiligo prevalence among probands' ﬁrst-degree relatives pegged
at approximately 7.0% for Caucasians and 2.6% for Chinese people.
The heritability of GVs is 50%, and the concordance of GV in
monozygotic twins is 23%.5 Together, these data indicate that GV is
a complex, polygenic multifactorial trait.
It is well known that there is a tendency for multiple autoim-
mune diseases to occur concomitantly in some patients. Perhaps
the earliest descriptionwas given in 1855, when Addison 7 reported
a patient with idiopathic adrenal insufﬁciency, vitiligo, and perni-
cious anemia. Over the next century, numerous case reports
described the co-occurrence of GV and various other autoimmune
diseases. In 1980, Neufeld et al.7 suggested a classiﬁcation scheme
for the so-called autoimmune polyglandular syndromes based on
clinical grounds: APS-1 (a rare autosomal recessive form), APS-2
(Schmidt syndrome), APS-3 (autoimmune thyroid disease with atier Taiwan LLC. All rights reserved.
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(all other autoimmune diseases). Recently, people realized that
the “multiple autoimmune disease” is more complex, and GV is part
of a more general autoimmune disease diathesis. In 2003, Alkha-
teeb et al5 reported that >20% of Caucasian GV patients had at least
one autoimmune disease, whereas Zhang et al8 reported that only
7.77% of GVs co-occur with other autoimmune diseases in Chinese
patients. The ﬁndings were in accordance with other Asian re-
ports.9 These ﬁndings indicate that GVs have a genetically deter-
mined susceptibility to the speciﬁc group of autoimmune diseases,
most likelymediated by shared susceptibility genes that predispose
certain individuals to these diseases. The concurrent rate is lower in
Asian GVs, maybe because of the heterogeneity between different
populations.
Genome-wide linkage studies and candidate gene studies
Genetic linkage studies are best suited to detecting relatively rare
disease susceptibility alleles with large effects, as in multiplex
families. Genome-wide linkage studies of numerous other Cauca-
sian multiplex GV families identiﬁed additional linkage signals on
chromosomes 7, 8, 9,11,13,17,19, and 22.5,10 Parallel genetic linkage
studies of GV in Han Chinese detected linkage signals on chromo-
somes 1, 4, 6, 14, and 22.11,12 These linkage signals generally did not
correspond to those detected in Caucasian families, suggesting that
different genes might underlie GV susceptibility in these differentTable 1 A summary of loci associated with GV by GWASs up to March 2014.
Type CHR Gene SNPs#
HLA-related 6p21.32 HLA rs7758128
6p21.32 HLA rs3806156
6p21.33 HLA rs11966200
6p21.33 HLA rs9468925
6p22.1 HLA rs6904029
Melanin-related 11q14.3 TYR rs1393350
11q21 TYR rs4409785
12q13.2 PMEL-IKZF4 rs10876864
12q13.2 IKZF4 rs2456973
15q13.1 OCA2 rs1129038
Immune-related 2q24.2 IFIH1 rs2111485
3p13 FOXP1 rs17008723
3q13.33 CD80 rs59374417
3q28 LPP rs9851967
3q28 LPP rs1464510
6q15 BACH2 rs3757247
6q27 RNASET2-FGFR1OP rs2236313
8q24.22 TG-SLA rs853308
10p15.1 IL2RA-RBM17-PFKB3 rs706779
10q25.3 CASP7 rs3814231
11p13 CD44 rs10768122
11q23.3 CXCR5-DDX6 rs638893
12q24.12 SH2B3 rs4766578
14q12 GZMB rs8192917
21q22.3 UBASH3A rs11203203
22q12.3 C1QTNF6 rs229527
22q13.2 TOB2 rs4822024
1p13.2 PTPN22 rs2476601
6q27 CCR6 rs6902119
Others 1p36.23 RERE rs4908760
2p16.3 KCNK12 rs6544997
4p16.1 CLNK rs16872571
6q27 SMOC2 rs13208776
10q22.1 SLC29A3-CDH23 rs1417210
10q22.3 ZMIZ1 rs11593576
16q12.2 KIAA1005 rs3213758
16q24.3 MC1R rs9926296
18q21.31 ATP8B1 rs10503019
19p13.3 TICAM1 rs6510827
21q22.11 HUNK rs2833607
CI ¼ conﬁdence interval; CHR ¼ chromosome regions; GV ¼ generalized vitiligo; GWASpopulations. The genetic loci discovered by genome-wide linkage
studies usually encompass several megabases. The diversity of re-
gions proposed has created a challenge in ﬁne mapping. A number
of different candidate genes for GV have been reported on the basis
of candidate gene studies.13 However, only a few biological candi-
date genes have been strongly supported by positive results in
multiple studies, such as HLA,14e16 PTPN22,17 NALP1,18 and XBP1,19,20
which have been consistently replicated in multiple studies.
Candidate gene studies are highly subject to false-positive results,
owing to the inadequate ethnic matching of cases and controls,
population stratiﬁcation, inadequate statistical power, and inade-
quate correction for multiple testing.
Genome-wide association study
GWAS is a high-throughput technology capable of “pinpointing”
disease-causing genes (in contrast to genome-wide linkage anal-
ysis). Unlike candidate gene association studies, GWASs can be
corrected for population stratiﬁcation and appropriate multiple
testing, and are not subject to a priori bias by choice of candidate
genes. Accordingly, GWASs have yielded reproducible association
signals that appear to represent true susceptibility genes for many
complex diseases.
Recently, GWASs have succeeded in identifying a veritable
cornucopia of GV susceptibility genes, encoding components of
biological networks that largely regulate elements of the immuneContext p OR (95% CI) Population
UTR-5 8  1011 NR European ancestry
Intron 7  1019 1.42 (1.32e1.54) European ancestry
Intron 1  1048 1.9 (1.74e2.07) Chinese
UTR-5 2  1033 1.35 (1.28e1.41) Chinese
ncRNA 1  1021 1.49 (1.37e1.61) European ancestry
Intron 2  1018 1.53 (1.39e1.68) European ancestry
UTR-3 2  1013 1.34 (NR) European ancestry
UTR-3 8  1012 1.18 (1.13e1.24) Chinese
Intron 3  1014 1.29 (NR) European ancestry
UTR-3 4  108 1.22 (NR) European ancestry
UTR-5 5  1015 1.3 (NR) European ancestry
1  108 1.33 (NR) European ancestry
UTR-5 4  1010 1.34 (NR) European ancestry
Intron 9  108 1.14 (1.09e1.19) Chinese
Intron 1  1011 1.31 (1.21e1.41) European ancestry
Intron 3  108 1.2 (NR) European ancestry
Intron 1  1016 1.2 (1.15e1.25) Chinese
Intron 2  108 1.2 (NR) European ancestry
Intron 3  109 1.27 (1.17e1.37) European ancestry
Intron 4  108 1.23 (NR) European ancestry
UTR-3 2  109 1.22 (NR) European ancestry
UTR-5 2  109 1.22 (1.14e1.30) Chinese
Intron 4  1018 1.32 (NR) European ancestry
Missense 3  108 1.28 (1.17e1.39) European ancestry
Intron 1  109 1.27 (1.18e1.38) European ancestry
Missense 2  1016 1.38 (1.28e1.50) European ancestry
7  1010 1.28 (NR) European ancestry
1  107 1.39 (1.23e1.57) European ancestry
UTR-5 4  107 1.23 (NR) European ancestry
Intron 7  1015 1.36 (1.26e1.48) European ancestry
UTR-5 7  106 NR Romanian
UTR-5 2  108 1.21 (NR) European ancestry
Intron 9  108 NR Romanian
UTR-3 2  108 1.14 (1.09e1.19) Chinese
Intron 8  107 1.14 (1.09e1.20) Chinese
Missense 6  1011 2.77 (2.04e3.76) Korean
Intron 2  1013 1.27 (NR) European ancestry
Intron 3  106 NR Romanian
Intron 9  108 1.19 (NR) European ancestry
UTR-3 2  106 NR Romanian
¼ genome-wide association study; NR ¼ not reported; OR ¼ odds ratio.
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2009, numerous GWASs have been performed in patients with GV
in various ethnic populations21e28 and identiﬁed >30 genes/loci
(including suggestive loci; Table 1). The proteins encoded by the
genes detected by these GV GWASs comprise components of
immunoregulatory pathways that span the melanocyte, dendritic
cells of the skin, regulatory lymphocytes, T lymphocytes, B lym-
phocytes, and back to the melanocyte. Interestingly, many of these
risk loci are shared between GV and other autoimmune diseases
(Table 2), implying that common molecular pathways exist among
various autoimmune disorder processes. The association of 24 non-
major histocompatibility complex (MHC) loci GV genes/loci
(p < 5  108) resulted in a dramatic expansion of our under-
standing of the genetic basis of GV.Human leukocyte antigen
The human leukocyte antigen (HLA) is the most gene-dense region
of the genome, encoding >120 functional genes in humans
distributed over a 3.6-Mbp region. Many of these genes function in
the immune system. This region has been associatedwith almost all
diseases involving autoimmunity, inﬂammation, and host defense
against infections. To date, the main GV GWASs in Caucasian and
Chinese populations have identiﬁed the HLA region as the strongest
determinator of genetic risk.22,24,25 The HLA can be subdivided into
three classes (I, II, and III) with a strong linkage disequilibrium (LD)
spanning the region.
Both Caucasian and Chinese GV GWASs detected major associ-
ation signals in the MHC on chromosome 6p21.3, although the
speciﬁc associations differed between the two populations. The
major MHC association signals were in the class I and II gene re-
gions for Caucasians and in the class III gene region for the Chinese.
In Caucasians, two major MHC association peaks were found.22
One association [including 3 single nucleotide polymorphisms
(SNPs): rs12206499, rs3823355, and rs6904029] was in the class I
gene region, between HLA-A (encoding the MHC class I, HLA-A
molecule) and HCG9 (encoding the HLA complex group 9). The
second association (including 2 SNPs: rs532098 and rs3806156)Table 2 GV risk loci involved in function and shared with other autoimmune diseases.
Function Chro
Regulates T cell receptor signaling 1p13
Involved in antiviral innate immune responses 2q24
Induces T cell proliferation and cytokine production 3q13
Unknown 3q28
A positive regulator of immunoreceptor signaling 4p16
Presents peptide antigens 6p21
A transcriptional repressor of B cells 6q15
Regulates B cell differentiation, function of dendritic and Th17 cells 6q27
Unknown 6q27
Regulates antigen receptor signaling 8q24
Regulates lymphocyte response to bacteriavia IL2 10p1
Unknown 10q2
Regulates melanocyte development, function and survival 10q2
An executioner protein of apoptosis and inﬂammation 10q2
Plays a role in T cell development 11p1
involves in B cell migration 11q2
Regulates T cell activation 12q1
Regulates the development of both B and T cells 12q2
14q1
Regulates T cell receptor signaling 21q2
Increases monocyte IL-10 synthesis 22q1
GV ¼ generalized vitiligo; IL ¼ interleukin.
a The loci that have been shown to be associated with other autoimmune diseases: Cro
psoriasis (PS), rheumatoid arthritis (RA), type 1 diabetes (T1D), ulcerative colitis (UC),
disease (AD), Graves' disease (GD), autoimmune thyroid disease (ATD), amyotrophic later
diabetes (PHID) syndrome.was in the class II gene region, betweenHLA-DRB1 (theMHC class II,
DR beta 1 gene) and HLA-DQA1 (the MHC class II, DQ alpha 1 gene).
There were a strong LD between the risk allele (G) at rs12206499
and HLA-A*02, and a moderate LD between the risk allele (T) at
rs532098 and HLADRB1*04, which were consistent with previous
reports of an association between GV and both the HLA-A*02
allele29 and the HLA-DRB1*04 allele.30 In addition, a quantitative
trait locus was identiﬁed for vitiligo age of onset in the MHC class II
region, located near c6orf10-BTNL2 (rs7758128), which highlights
the differing roles played by genes involved in vitiligo susceptibility
versus vitiligo phenotype.25
For the Chinese study, there were two major independent as-
sociation signals within theMHC region.24 Themost signiﬁcant SNP
(rs11966200) is located in the HLA class III region. Another inde-
pendent statistically signiﬁcant association (rs9468925) is located
at the HLA-CeHLA-B region. Two haplotypes (AGAAGGCGAAC and
CAGGAAAAGGG) on rs9468925 and rs11966200 as well as an
additional nine top SNPs surrounding themwithin the MHC region
were highly associated with GV. By imputing the HLA class I alleles
and test for association, three alleles (HLA-A*3001, HLA-B*1302, and
HLA-C*0602) within the MHC region reveals strong associations,
which is consistent with the previous ﬁndings of HLA association in
the Chinese population.15 Overall, all of these studies highlight the
involvement of HLA genes to the pathogenesis of GV.Melanin-related genes
TYR (11q14.3)
11q14.3 is an interesting region consisting of 37 SNPs spanning the
TYR region. The strongest association was rs1393350
(p ¼ 3.24  1013; odds ratio, 1.54), which was in tight LD with the
nonsynonymous (R402Q) SNP, rs1126809.22 TYR encodes tyrosi-
nase, an enzyme of the melanocyte that catalyzes the rate-limiting
steps of melanin biosynthesis. It is also a major autoantigen in GV.
Meanwhile, the signiﬁcant SNPs were reported to be associated
with malignant melanoma in inverse odds ratio, suggesting that
vitiligo and malignant melanoma are mediated by different ormosome Gene Other autoimmune diseasea
.2 PTPN22 T1D, SLE, GD, RA, AD, psoriasis, IBD
.2 IFIH1 T1D, GD, RA, MS, psoriasis
.33 CD80 SLE, CeD
LPP CeD, RA, T1D
.1 CLNK ALS
.3 HLA Many
BACH2 T1D, CeD, CD, RA
CCR6 IBD, RA, GD
SMOC2 T1D, RA
.22 TG-SLA ATD
5.1 IL2RA T1D, MS, RA, SLE
2.1 SLC29A3 MS, PHID
2.3 ZMIZ1 IBD
5.3 CASP7 RA, T1D
3 CD44 Lupus
3.3 CXCR5 SLE, CeD, RA
3.2 IKZF4 T1D, AA
4.12 SH2B3 T1D, CeD, RA, MS
2 GZMB RA
2.3 UBASH3A T1D, RA, SLE, CeD
2.3 C1QTNF6 T1D, RA, GD
hn's disease (CD), alopecia areata (AA), celiac disease (CeD), multiple sclerosis (MS),
inﬂammatory bowel disease (IBD), systemic lupus erythematosus (SLE), Addison's
al sclerosis (ALS), and pigmented hypertrichotic dermatosis with insulin-dependent
Z. Zhang, L.F. Xiang / Dermatologica Sinica 32 (2014) 225e232228perhaps even inverse biologic mechanisms. 11q14.3 was only re-
ported to be associated with Caucasians, and the most signiﬁcant
SNP is a single peptide in Chinese people.
PMEL (12q13.2)
12q13.2 is a complicated region including a host of genes and has
been reported by both Caucasian and Chinese GV studies. Using
skin biopsy transcriptome analysis, PMEL was shown to have the
strongest differential expression between vitiligo lesional skin and
vitiligo perilesional normal skin.27 PMEL encodes a melanocyte-
speciﬁc type I transmembrane glycoprotein, which is enriched in
melanosomes and plays an important role in the structural orga-
nization of premelanosomes. Vaccination of PMEL-speciﬁc TCR
transgenic mice bearing large subcutaneous B16 melanoma tumors
with PMEL peptide together with IL-2-induced T cell activation
in vivo led to tumor regression as well as vitiligo.29 It was shown
that there is an increase in the frequency of antigen speciﬁc CD8þ T
cells in the circulation of HLA-A2-postive vitiligo patients, and the T
cells exhibit reactivity to modiﬁed PMEL peptide epitopes. This
reactivity also appears to correlate with the patient's active disease
and supports the notion that there is a cell-mediated immuno-
pathologic mechanism in vitiligo.30
OCA2 (15q13.1)
In 15q13.1, the strongest SNP (rs1129038) at the 30 untranslated
region (UTR) of the gene OCA2 is associated with GV in Cauca-
sians.26 OCA2 encodes a melanosomal membrane transporter
involved in small molecule transport, speciﬁcally tyrosineda pre-
cursor of melanindand has a major role in determining skin, hair,
and eye color. OCA2 is analogous to TYR: both genes encode mela-
nocyte antigens presented by HLA-A*02. In both genes, vitiligo
protection is associated with reduced amounts of functional pro-
tein, and for both genes, susceptibility to vitiligo and melanoma
constitutes genetic opposites, perhaps modulating immune sur-
veillance for melanoma.
MC1R (16q24.3)
16q24.3 was reported by Caucasian GV GWASs showing complex
association of SNPs spanning 89647951e90078022. The association
region contains 20 genes, and Jin et al26 speculated that MC1R was
the candidate gene in this region. The MC1R gene is the major
determinant of human pigmentation, encoding a G-protein coupled
receptor (a regulator of melanogenesis and minor vitiligo auto-
antigen) with a high afﬁnity for the a-melanocyte-stimulating
hormone, and which is genetically associated with malignant
melanoma and with skin and hair color.
Immune-related genes
Most GV susceptibility loci/genes discovered by GWASs were
immune-related loci/genes. We summarize the loci and the
candidate genes as speculated by authors in the following
subsections.
IFIH1 (2q24.2)
IFIH1, also known as melanoma differentiation-associated protein
5, is a cytosolic RNA sensor belonging to the retinoic acid-inducible
gene I-like receptor family. IFIH1 encodes a DEAD box protein, an
interferon-induced RNA helicase that is involved in antiviral innate
immune responses.31 IFIH1 also triggers the activation of interferon
regulatory factors 3 and 7 and NF-kB via a mitochondrial antiviralsignaling protein, leading to antiviral and proapoptotic responses,32
which is associated with type 1 diabetes (T1D),33 Graves' disease
(GD),34 multiple sclerosis (MS),35 psoriasis,36 and rheumatoid
arthritis (RA).37 A large-scale association study in Caucasians
identiﬁed that an SNP (rs2111485) at the 50 UTR of IFIH1 is associ-
ated with GV.27 These genetic association studies have demon-
strated an important role for IFIH1 in autoimmune diseases.
FOXP1 (3p13)
FOXP1 belongs to subfamily P of the forkhead box (FOX) tran-
scription factor family. This encodes a widely expressed transcrip-
tion factor that is essential for the development of B cells, quiescent
naïve T cells, and monocytes, and is paralogous to FOXP3, which
encodes a transcriptional regulator of regulatory T cell develop-
ment and function and is the defective gene in the IPEX multiple
autoimmune disease syndrome.38 Foxp1 conditional knockout
mice have premature cell-autonomous hyperactivation of early
thymocytes to CD4þ and CD8þ mature T cells with effector func-
tions.39 The reported SNP (rs17008723) at FOXP1 is associated with
GV in Caucasians.23
CD80 (3q13.33)
CD80 encodes B7-1, a membrane receptor that is on antigen-
presenting cells and that induces T cell proliferation and cytokine
production, which is a surface protein on activated B cells, mono-
cytes, and dendritic cells that costimulates T cell priming. The
encoded protein is also activated by the binding of CD28 or CTLA-4,
which can act as a receptor for adenovirus subgroup B andmay play
a role in lupus neuropathy. Its expression is associated to oxidative
DNA damage and TLR4-NFkB signaling.40 This locus has been re-
ported to be associated with systemic lupus erythematosus (SLE)41
and celiac disease (CeD).42 The risk SNP (rs59374417) at upstream
of CD80 is associated with GV in Caucasians.26
CLNK (4p16.1)
CLNK is a member of the SLP76 family of adaptors. CLNK encodes
the mast cell immunoreceptor signal transducer,43 which plays a
role in the regulation of immunoreceptor signaling, including PLC-
gamma-mediated B cell antigen receptor signaling and FC-epsilon
R1-mediated mast cell degranulation. CLNK has also been associ-
ated with amyotrophic lateral sclerosis.44 The identiﬁed SNP
(rs16872571) at upstream of CLNK is associated with GV in
Caucasians.26
BACH2 (6q15)
BACH2 encodes BTB and CNC homology 1, basic leucine zipper
transcription factor 2, a B-cell-speciﬁc transcription factor that has
been shown to regulate the BLIMP1 gene (also known as PRDM1, a
validated RA susceptibility locus) in mice, which in turn inﬂuences
plasma cell differentiation and promotes the antibody class
switch.45 This locus has been reported to be associated with T1D,46
CeD,42 and Crohn's disease.47 The identiﬁed SNP (rs3757247) at
intron of BACH2 is associated with GV in Caucasians.26
RNASET2eFGFR1OPeCCR6 (6q27)
The glycoprotein RNASET2 is the only humanmember of the Rh/T2/
S family of RNases, which is potentially involved in tumorigenesis,
and its expression is reduced in ovarian tumors and melanoma.
FGFR1OP encodes a largely hydrophilic protein, thought to be a
leucine-rich protein family member, which might have an
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erythroid lineage. CCR6 encodes a receptor (chemokine receptor 6)
for macrophage inﬂammatory protein-3a (CCL20) expressed on
unactivated memory B and T cells, T-helper 17 cells, and some
dendritic cells, and plays a key role in B cell differentiation and
tissue-speciﬁc migration of dendritic and T cells during inﬂam-
matory and immunological responses.48 This locus has been asso-
ciated with inﬂammatory bowel disease,49 RA,50 and GD.51 Risk
SNPs rs6902119 and rs2236313 at the region were identiﬁed to be
associated with GV in Caucasian and Chinese populations,
respectively.23,24
TGeSLA (8q24.22)
TG encodes thyroglobulin, and SLA encodes Src-like adaptor pro-
tein, a regulator of antigen receptor signaling. TG is associated with
autoimmune thyroid disease, which affects approximately 17% of
individuals with vitiligo.5 However, it is not apparent what role
thyroglobulin might play in vitiligo pathogenesis, suggesting that
the association of vitiligo with the TGeSLA locus may derive from
SLA rather than TG.26 SLA might likewise account for the reported
association of TG with autoimmune thyroid disease.
IL2RA (10p15.1)
IL2RA encodes the high-afﬁnity alpha subunit (also known as CD25)
of the heterotrimeric IL-2 receptor complex. The IL-2/IL-2RA
signaling pathway plays a major role in the maintenance of pe-
ripheral self-tolerance. It is particularly important for the devel-
opment and activity of the regulatory CD4þCD25þFoxp3þ T cells
(Tregs), which suppress T cell immune responses.52 The IL-2RA
molecule is not only constitutively expressed at high levels on
Tregs but also becomes upregulated on activated effector T cells and
certain innate immune cell subsets. It has been reported to be
associated with MS,53 T1D,53 RA,54 and SLE,55 which is also a
common susceptibility locus for GV in Caucasian and Chinese
populations.22,27
CASP7 (10q25.3)
CASP7 encodes caspase 7 [a member of the cysteine-aspartic acid
protease (caspase) family)], an executioner protein of cell apoptosis
and inﬂammation. It is associated with RA56 and has been sug-
gested as a positional candidate gene for IDDM17 in T1D.57 The
reported SNP (rs3814231) at intron of BACH2 is associated with GV
in Caucasians.26
CD44 (11p13)
CD44 encodes a cell surface glycoprotein with various functions,
and is involved in a number of biological processes including
lymphocyte migration, extravasation, homing, activation, and
apoptosis, especially those involving a role in T cell development.58
This locus has been shown to be associated with SLE.59 The sig-
niﬁcant association signal (SNP rs10768122) at the 30 UTR of CD44 is
associated with GV in Caucasians.26
CXCR5 (11q23.3)
CXCR5 encodes the receptor for CXC-chemokine ligand 13 (CXCL13),
a chemokine secreted by follicular stromal cells and a deﬁning
molecule for T cells with follicular-homing capability, localized to
the follicles. It is specialized for providing help to germinal-center B
cells during antibody responses to T cell-independent antigens. A
previously reported region is associated with SLE,60 CeD, and RA.61A strongly associated SNP, rs638893, at the 50 UTR of CXCR5 is
identiﬁed in GV from the Chinese population.27 CXCR5 may be the
potential candidate gene for vitiligo; functional analysis is needed
for future study.
IKZF4 (12q13.2)
IKZF4 is a member of the Ikaros family of zinc-ﬁnger transcription
factors of T cell activation. A function study has shown that IKZF4 is
a critical coregulator of FoxP3-directed gene silencing during CD4þ
regulatory T cell differentiation,62 and the locus is identiﬁed to be
associated with T1D63 and alopecia areata.64 The identiﬁed SNP
(rs2456973) at intron of IKZF4 is associated with GV in
Caucasians.26
SH2B3 (12q24.12)
This gene encodes a member of the SH2B adaptor family of pro-
teins, which are involved in a range of signaling activities by growth
factor and cytokine receptors (a key negative regulator of cytokine
signaling that regulates the development of both B and T cells). This
locus has been identiﬁed to be associated with multiple autoim-
mune diseases, including T1D,65 CeD,66 RA,67 and MS.68 The
strongly associated SNP (rs4766578) at the intron of SH2B3 is
identiﬁed to be conferring the risk for GV in Caucasians.26
GZMB (14q12)
Granzyme B, a proapoptotic serine protease, has been studied
extensively. In the target cell, apoptosis occurs upon granzyme B
uptake through the pores formed by perforin. Studies suggest that
granzyme B may enter the cell rather using cation-independent
mannose-6-P receptor, followed by caspase activation and
apoptosis. Notably, the GZMB cleavage of melanocyte proteins that
constitute GV autoantigens may contribute to the initiation and
propagation of autoimmunity directed against melanocytes
in vivo.69 The SNP (rs8192916) located in GZMB is associated with
the progression of joint destruction in RA.70 In Caucasians, a
missense variant rs8192917 at GZMB is associated with the risk of
developing GV.22
UBASH3A (21q22.3)
UBASH3A is a suppressor of T cell receptor signaling, underscoring
antigen presentation to T cells as a critical shared mechanism of
disease pathogenesis. It has also been reported that SLE T cells,
compared with control T cells, undergo an increased rate of
apoptosis, which contributes to SLE pathogenesis. Changes in the
UBASH3A structure or expression levels can affect the binding with
AIF leading to an alteration in the apoptosis level. The UBASH3A
gene is associated with some autoimmune diseases, such as T1D,71
CeD,61 RA,72 and SLE,73 suggesting that this gene could play an
important role in the pathogenesis of autoimmune disorders. The
SNP (rs11203203) at the intron of the gene is associated with GV in
Caucasians.22
C1QTNF6 (22q12.3)
The human C1QTNF6 induces the expression of IL-10 mRNA and
protein in monocytic cells. The globular domain of CTRP6 also
stimulates the phosphorylation of p42/44 MAPK, whichdwhen
blocked by cotreatment of cells with a selective p42/44 MAPK
inhibitordabolishes CTRP6-mediated IL-10 expression. Several
studies have reported an association of markers at the C1QTNF6
locus with T1D,48 RA,74 CeD,75 and GD.76 A missense variant
Z. Zhang, L.F. Xiang / Dermatologica Sinica 32 (2014) 225e232230rs229527 at C1QTNF6 is associated with the risk of development to
GV in Caucasians.22 In Chinese individuals, the SNP (rs2051582) at
the locus is identiﬁed with suggestive evidence of association.27
TOB2 (22q13.2)
TOB2 belongs to the TOB/BTG1 family of antiproliferative proteins,
which permits the TOB proteins to coordinate their diverse roles in
controlling cell growth and differentiation via their multiple modes
of modulating mRNA turnover and arresting cell growth. In addi-
tion, it is regarded as a regulator of cell cycle progression that is
involved in T cell tolerance.74 The SNP (rs4822024) in close prox-
imity to TOB2 is associated with GV in Caucasians.26
Other related genes
RERE (1p36.23)
The RERE gene encodes a member of the atrophin family of argi-
nineeglutamic acid (RE) dipeptide repeat-containing proteins. The
encoded protein plays an important role in the transcriptional
process. Furthermore, the overexpression of RERE triggers caspase-
3 activation, leading to cell death. These ﬁndings shed considerable
light on the function of RERE, which may provide an important link
between the role of promyelocytic leukemia oncogenic domains in
the control of apoptosis and tumorigenesis.77 An LD analysis
identiﬁed RERE gene SNP rs11121179 as potentially associated with
bone mineral density.78 The SNP (rs4908760) at the intron of the
gene is associated with GV in Caucasians.22
LPP (3q28)
LPP encodes a subfamily of Lim domain proteins, whose members
are characterized by an N-terminal proline-rich region and three C-
terminal Lim domains, which is a negative regulator of insulin
signaling pathway and plays important roles in the pathogenesis of
insulin resistance.79 This locus is also found to be associated with
T1D,65 CeD,80 and RA,67 suggesting that this gene could play an
important role in the pathogenesis of autoimmune disorders. The
SNP (rs1464510) at the intron of the gene is associated with GV in
Caucasians.22
SLC29A3eCDH23 (10q22.1)
The associated SNP (rs1417210) at the locus is located in an LD block
that contains SLC29A3 and CDH23, which is associated with GV in
Chinese.28 SLC29A3 encodes the equilibrative nucleoside trans-
porter hENT3, and mutations in SLC29A3 have been associated with
the H syndrome (MIM 612391), which can include cutaneous hy-
perpigmentation.81 For this locus, another candidate gene, CDH23,
belongs to a member of the cadherin superfamily, which encodes
calcium-dependent cellecell adhesion glycoproteins, and muta-
tions in CDH23 cause the Usher syndrome (an autosomal recessive
disorder characterized by retinitis pigmentosa and hearing
loss).82,83
KIAA1005 (16q12.2)
In a Korean study, a missense SNP at the KIAA1005 gene is strongly
associated with segmental vitiligo.28 This gene, which is called
retinitis pigmentosa GTPase regulator-interacting protein 1-like
(RPGRIP1L) gene, has also been associated with certain clinical
manifestations, particularly ciliopathies as in DNAH5 with neuro-
logical, renal, and ocular manifestations.84 The neural dysfunctionin the pathogenesis of segmental vitiligo and KIAA genes for orga-
nization and function in the brain may support this association.85Conclusion
In the past 4 years, GWASs have contributed tremendously to the
identiﬁcation of key loci that are associated with the risk of
developing GV. Accordingly, for GVdas with many other dis-
easesdwe have entered a new era of understanding the true un-
derlying pathobiology, which in this case appears to be
predominantly autoimmune. Compared with Chinese GV GWASs,
Caucasian GV GWASs have been hugely successful by detecting
more than 20 new susceptibility loci. Although we have 97% power
to detect the genes, we could barely replicate the results obtained
in Caucasian populations. Heterogeneity may be one of the reasons
(as mentioned above), as more than 20% of Caucasian GV patients
had at least one autoimmune disease compared with 7.7% in Chi-
nese GV patients; this explains why there were so many immune-
related genes discovered among Caucasian patients. The priority
given to selecting GV with other autoimmune diseases in Cauca-
sians may be another reason. Here, we summarized and evaluated
the importance of newly discovered loci in the respective biology
functions and suggested new etiologic clues (especially for roles in
the immune system) to GV development. A move to fully identify
these genetic variants will help pave the way toward accurate ge-
netic diagnosis and render personalized treatment for patients
with GV a reality.Acknowledgments
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